Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celogos
Evry, France
- Ownership
- Private
- Development stage
- Other
01
Overview
Phase II clinical trial ongoing as of 2007 for RCD1 autologous cell therapy in stress urinary incontinence; Phase III planned for Q1 2007.[1]
- Therapeutic areas
- Women's Health
- Modalities
- Cell therapy
- Industry
- Biotech
02
Partnerships
HRA PharmaLaboratoire HRA PharmaStem Cell Sciences
Beyond the preview
Go deeper on Celogos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celogos.